Literature DB >> 28084526

[Gastric tumors and tumor precursors].

C Röcken1.   

Abstract

Gastric cancer is the fifth (men) and sixth (women) most common cause of cancer-related death in Germany. Despite a declining incidence of distal gastric cancer, the prognosis remains dismal: the 5‑year survival rate ranges between 35% for women and 31% for men. The majority are adenocarcinomas, which occur sporadically, familial or hereditary. Adenomas and intraepithelial neoplasms are considered as precursor lesions. Recently, whole genome sequencing and comprehensive molecular profiling described four molecular subtypes of gastric cancer: Epstein-Barr virus (EBV) positive, microsatellite unstable, chromosomal unstable and genomically stable gastric cancer. Currently, only the TNM classification has stood the test of time for the assessment of patient prognosis. Neuroendocrine tumor types 1-3 and soft tissue tumors occur significantly less often in the stomach. Gastrointestinal stromal tumors and inflammatory fibroid polyps are among the more common soft tissue tumors of the stomach and show distinct phenotypes. This review gives an overview of the current World Health Organization (WHO) classification of gastric tumors.

Entities:  

Keywords:  Gastric cancer; Gastrointestinal tract; Inflammatory fibroid polyp; Intraepithelial neoplasia; Neuroendocrine neoplasia; WHO classification

Mesh:

Year:  2017        PMID: 28084526     DOI: 10.1007/s00292-016-0259-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  45 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

Review 2.  Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature.

Authors:  Nina Nandy; Joshua A Hanson; Robert G Strickland; Denis M McCarthy
Journal:  Dig Dis Sci       Date:  2015-12-29       Impact factor: 3.199

3.  Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.

Authors:  Taiki Hashimoto; Reiko Ogawa; Akiko Matsubara; Hirokazu Taniguchi; Kokichi Sugano; Mineko Ushiama; Teruhiko Yoshida; Yae Kanai; Shigeki Sekine
Journal:  Histopathology       Date:  2015-05-14       Impact factor: 5.087

4.  Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.

Authors:  Mikako Osada; Shinichi Aishima; Minako Hirahashi; Nobuyoshi Takizawa; Shunsuke Takahashi; Kazuhiko Nakamura; Masao Tanaka; Yoshihiko Maehara; Ryoichi Takayanagi; Yoshinao Oda
Journal:  Hum Pathol       Date:  2014-02-20       Impact factor: 3.466

Review 5.  Histopathological classification of nonantral gastric endocrine growths in man.

Authors:  E Solcia; C Bordi; W Creutzfeldt; Y Dayal; A D Dayan; S Falkmer; L Grimelius; N Havu
Journal:  Digestion       Date:  1988       Impact factor: 3.216

6.  Seventh edition (2010) of the AJCC/UICC staging system for gastric adenocarcinoma: is there room for improvement?

Authors:  Manali I Patel; Kim F Rhoads; Yifei Ma; James M Ford; Brendan C Visser; Pamela L Kunz; George A Fisher; Daniel T Chang; Albert Koong; Jeffrey A Norton; George A Poultsides
Journal:  Ann Surg Oncol       Date:  2012-11-13       Impact factor: 5.344

7.  Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Authors:  Salah-Eddin Al-Batran; Ralf D Hofheinz; Claudia Pauligk; Hans-Georg Kopp; Georg Martin Haag; Kim Barbara Luley; Johannes Meiler; Nils Homann; Sylvie Lorenzen; Harald Schmalenberg; Stephan Probst; Michael Koenigsmann; Matthias Egger; Nicole Prasnikar; Karel Caca; Jörg Trojan; Uwe M Martens; Andreas Block; Wolfgang Fischbach; Rolf Mahlberg; Michael Clemens; Gerald Illerhaus; Katja Zirlik; Dirk M Behringer; Wolff Schmiegel; Michael Pohl; Michael Heike; Ulrich Ronellenfitsch; Martin Schuler; Wolf O Bechstein; Alfred Königsrainer; Timo Gaiser; Peter Schirmacher; Wael Hozaeel; Alexander Reichart; Thorsten O Goetze; Mark Sievert; Elke Jäger; Stefan Mönig; Andrea Tannapfel
Journal:  Lancet Oncol       Date:  2016-10-22       Impact factor: 41.316

8.  Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy.

Authors:  Karen Becker; James D Mueller; Christoph Schulmacher; Katja Ott; Ulrich Fink; Raymonde Busch; Knut Böttcher; J Rüdiger Siewert; Heinz Höfler
Journal:  Cancer       Date:  2003-10-01       Impact factor: 6.860

9.  Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine.

Authors:  Viktoria S Warneke; Hans-Michael Behrens; Jochen Haag; Katharina Balschun; Christine Böger; Thomas Becker; Matthias P A Ebert; Florian Lordick; Christoph Röcken
Journal:  Diagn Mol Pathol       Date:  2013-09

10.  MET in gastric cancer--discarding a 10% cutoff rule.

Authors:  Marie-Luise Metzger; Hans-Michael Behrens; Christine Böger; Jochen Haag; Sandra Krüger; Christoph Röcken
Journal:  Histopathology       Date:  2015-07-14       Impact factor: 5.087

View more
  1 in total

1.  [Gastric tumors].

Authors:  G B Baretton
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.